Myelodysplastic syndromes (MDS) belong to the malignant diseases of the hematopoietic system that occur primarily in older ...
Allogeneic hematopoietic cell transplantation achieved a 3-year overall survival of 69% in adults aged 18 to 40 years with ...
Morning Overview on MSN
Daily vitamin C was tied to fewer deaths in a trial of people with precancerous blood disorders
Of 35 people who died during follow-up in a randomized trial of daily vitamin C, 24 had been taking placebo and 11 had been ...
Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., today announced positive topline results from the Phase 3 AZTOUND trial evaluating pharmacokinetic (PK) exposure, safety and efficacy of an ...
A simple measurement that can be taken from any routine blood sample is attracting renewed attention as a possible prognostic ...
The oral combination of azacitidine and cedazuridine (ASTX030) met its primary endpoint in phase 3 AZTOUND study of patients ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
TP53 mutations occurred in 3% of myeloproliferative neoplasms (MPNs) but 10% of myelofibrosis or blast-phase cohorts in a ...
SPV, CERO 1236, to raise capital directly into subsidiary and not dilute existing SRX Global shareholdersProposed acquisition expected to ...
Seven occupational solvents have been linked to Parkinson’s disease, with greater risk among people exposed to more than one, ...
Taiho Oncology Announced Positive Phase 3 Trial Results for Azacitidine and Cedazuridine in MDS and CMML / azacitidine, cancer, cedazuridine, chronic ...
Contemporary challenges, the value of institutional collaboration and new therapeutic options in the management of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results